Awareness and Ever-Use of Electronic Cigarettes Among U.S. Adults, 2010-2011Brett King, Shanta R. Dube, Sameer Alam et al.|Nicotine & Tobacco Research|2013Cited by 397
Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trialsEric L. Simpson, Kristian Reich, Amy M. DeLozier et al.|British Journal of Dermatology|2020Cited by 377
Tofacitinib Citrate for the Treatment of VitiligoBrittany G. Craiglow, Brett King|JAMA Dermatology|2015Cited by 255
Crystal Structure and Photodynamic Behavior of the Blue Emission Variant Y66H/Y145F of Green Fluorescent ProteinRebekka M. Wachter, S. James Remington, Brett King et al.|Biochemistry|1997Cited by 164
Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areataBrett King, James V. Cassella, Natasha Atanaskova Mesinkovska et al.|Journal of the American Academy of Dermatology|2022Cited by 80